Metastatic Breast Cancer: Overview of Treatment

Suhail M. Ali, H. A. Harvey, Allan Lipton

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Patients with metastatic breast cancer have a median survival of 2 to 3 years. Twenty percent of the patients who present with bone-only metastasis will be alive at 5 years from diagnosis. Current therapies are aimed at improving the quality of life, symptom control, and prolongation of survival. Newer endocrine and chemotherapeutic drugs are available to the medical oncologist for care of patients with metastatic breast cancer. We will briefly review the new advances in the treatment of metastatic breast cancer.

Original languageEnglish (US)
Pages (from-to)S132-S137
JournalClinical orthopaedics and related research
Issue number415 SUPPL.
StatePublished - Oct 2003

Fingerprint

Breast Neoplasms
Survival
Patient Care
Therapeutics
Quality of Life
Neoplasm Metastasis
Bone and Bones
Pharmaceutical Preparations
Oncologists

All Science Journal Classification (ASJC) codes

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Ali, Suhail M. ; Harvey, H. A. ; Lipton, Allan. / Metastatic Breast Cancer : Overview of Treatment. In: Clinical orthopaedics and related research. 2003 ; No. 415 SUPPL. pp. S132-S137.
@article{b775b546f67240c4a5dc5467f9526d2a,
title = "Metastatic Breast Cancer: Overview of Treatment",
abstract = "Patients with metastatic breast cancer have a median survival of 2 to 3 years. Twenty percent of the patients who present with bone-only metastasis will be alive at 5 years from diagnosis. Current therapies are aimed at improving the quality of life, symptom control, and prolongation of survival. Newer endocrine and chemotherapeutic drugs are available to the medical oncologist for care of patients with metastatic breast cancer. We will briefly review the new advances in the treatment of metastatic breast cancer.",
author = "Ali, {Suhail M.} and Harvey, {H. A.} and Allan Lipton",
year = "2003",
month = "10",
language = "English (US)",
pages = "S132--S137",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "415 SUPPL.",

}

Metastatic Breast Cancer : Overview of Treatment. / Ali, Suhail M.; Harvey, H. A.; Lipton, Allan.

In: Clinical orthopaedics and related research, No. 415 SUPPL., 10.2003, p. S132-S137.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Metastatic Breast Cancer

T2 - Overview of Treatment

AU - Ali, Suhail M.

AU - Harvey, H. A.

AU - Lipton, Allan

PY - 2003/10

Y1 - 2003/10

N2 - Patients with metastatic breast cancer have a median survival of 2 to 3 years. Twenty percent of the patients who present with bone-only metastasis will be alive at 5 years from diagnosis. Current therapies are aimed at improving the quality of life, symptom control, and prolongation of survival. Newer endocrine and chemotherapeutic drugs are available to the medical oncologist for care of patients with metastatic breast cancer. We will briefly review the new advances in the treatment of metastatic breast cancer.

AB - Patients with metastatic breast cancer have a median survival of 2 to 3 years. Twenty percent of the patients who present with bone-only metastasis will be alive at 5 years from diagnosis. Current therapies are aimed at improving the quality of life, symptom control, and prolongation of survival. Newer endocrine and chemotherapeutic drugs are available to the medical oncologist for care of patients with metastatic breast cancer. We will briefly review the new advances in the treatment of metastatic breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=0142157076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142157076&partnerID=8YFLogxK

M3 - Article

C2 - 14600603

AN - SCOPUS:0142157076

SP - S132-S137

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 415 SUPPL.

ER -